Literature DB >> 22345306

Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation.

Sima Allahverdian1, Parveer S Pannu, Gordon A Francis.   

Abstract

Smooth muscle cells (SMCs) are the main cell type in intimal thickenings and some stages of human atherosclerosis. Like monocyte-derived macrophages, SMCs accumulate excess lipids and contribute to the total intimal foam cell population. In contrast, apolipoprotein (Apo)E-deficient and LDL receptor-deficient mice develop atherosclerotic lesions that are macrophage- as opposed to SMC-rich. The lesser contribution of SMCs to lesion development in these mouse models has distracted attention away from the importance of SMC cholesterol homeostasis in the artery wall. Intimal SMCs accumulate excess amounts of cholesteryl esters when compared with medial layer SMCs, possibly explained by reduced ATP-binding cassette transporter A1 expression and ApoA-I binding to intimal-type SMCs. The aim of this review is to compare the relative contribution of monocyte-derived macrophages and SMCs to human vs. mouse atherosclerosis, and describe what is known about lipid uptake and removal mechanisms contributing to arterial macrophage and SMC foam cell formation. An increased understanding of the contribution of these cell types to lesion development will help to delineate their relative importance in atherogenesis and as potential therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345306     DOI: 10.1093/cvr/cvs094

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  50 in total

Review 1.  The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective.

Authors:  Mia Krolikoski; James Monslow; Ellen Puré
Journal:  Matrix Biol       Date:  2018-05-21       Impact factor: 11.583

2.  Atherogenesis in the Carotid Artery with and without Interrupted Blood Flow of Two Hyperlipidemic Mouse Strains.

Authors:  Jian Zhao; Chaoji Huangfu; Zhihui Chang; Andrew T Grainger; Zhaoyu Liu; Weibin Shi
Journal:  J Vasc Res       Date:  2019-09-19       Impact factor: 1.934

Review 3.  Beyond vascular inflammation--recent advances in understanding atherosclerosis.

Authors:  Dennis Wolf; Andreas Zirlik; Klaus Ley
Journal:  Cell Mol Life Sci       Date:  2015-06-23       Impact factor: 9.261

4.  Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis.

Authors:  Sean D Allen; Yu-Gang Liu; Taehyeung Kim; Sharan Bobbala; Sijia Yi; Xiaohan Zhang; Jaehyuk Choi; Evan A Scott
Journal:  Biomater Sci       Date:  2019-01-29       Impact factor: 6.843

5.  Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Authors:  Sean Allen; Yu-Gang Liu; Evan Scott
Journal:  Regen Eng Transl Med       Date:  2016-03-03

Review 6.  Inflammation, oxidative stress and renin angiotensin system in atherosclerosis.

Authors:  Kazim Husain; Wilfredo Hernandez; Rais A Ansari; Leon Ferder
Journal:  World J Biol Chem       Date:  2015-08-26

Review 7.  ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.

Authors:  Dimitry A Chistiakov; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Lab Invest       Date:  2016-05-16       Impact factor: 5.662

8.  Anti-atherogenic effect of trivalent chromium-loaded CPMV nanoparticles in human aortic smooth muscle cells under hyperglycemic conditions in vitro.

Authors:  Rituparna Ganguly; Amy M Wen; Ashley B Myer; Tori Czech; Soumyadip Sahu; Nicole F Steinmetz; Priya Raman
Journal:  Nanoscale       Date:  2016-03-28       Impact factor: 7.790

9.  TL1A inhibits atherosclerosis in apoE-deficient mice by regulating the phenotype of vascular smooth muscle cells.

Authors:  Dan Zhao; Jiaqi Li; Chao Xue; Ke Feng; Lipei Liu; Peng Zeng; Xiaolin Wang; Yuanli Chen; Luyuan Li; Zhisong Zhang; Yajun Duan; Jihong Han; Xiaoxiao Yang
Journal:  J Biol Chem       Date:  2020-09-22       Impact factor: 5.157

Review 10.  Smooth muscle cell fate and plasticity in atherosclerosis.

Authors:  Sima Allahverdian; Chiraz Chaabane; Kamel Boukais; Gordon A Francis; Marie-Luce Bochaton-Piallat
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.